23andMe, the genetic testing large as soon as valued within the billions, is now navigating Chapter 11 chapter and notifying thousands and thousands of present and former prospects that they could be eligible to file claims as a part of the restructuring course of. The corporate and 11 of its subsidiaries, together with Lemonaid Well being and LPRXOne, filed for chapter safety on March 23 of this yr within the Jap District of Missouri. Prospects have been alerted Sunday that they’ve till July 14 to file claims for losses incurred.
Support Greater and Subscribe to view content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
